Tulip A. Jhaveri and team report findings of a systematic review to identify factors contributing to unfavorable outcomes across each care cascade gap for tuberculosis disease in India.
Author summary Why was this study done? There have been an increasing number of cases of type 1 diabetes reported following Coronavirus Disease 2019 (COVID-19) vaccinations. The relationship between receiving COVID-19 vaccines and incident diabetes has not been examined in population-based studies. Several nationwide cohorts reported higher risks of incident diabetes following Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. The risk of incident diabetes following infection by SARS-CoV-2 Omicron variants may differ from that following infection by earlier variants. It is also uncertain how vaccination status may influence the risk. What did the researchers do and find? This study included 167,337 CoronaVac, 158,378 BNT162b2 recipients, and 145,199 COVID-19 patients with their respective 1:1 matched control. There was no evidence of increased risks of incident diabetes following COVID-19 vaccination. Regardless of predominant circulating variants, SARS-CoV-2
In a test-negative design case-control study, Dr. Thiago Cerqueira-Silva and colleagues, investigate the effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland.
In a test-negative design case-control study, Dr. Thiago Cerqueira-Silva and colleagues, investigate the effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland.
Using national surveillance data, Marta Bertran and colleagues aim to understand the characteristics of children and young people who died of COVID-19 in England between March 2020 and December 2021.